Preiss, D. and Sattar, N. (2013) Choice of medical therapy to lower triglycerides in those at risk of pancreatitis. Current Opinion in Lipidology, 24(6), pp. 532-533. (doi: 10.1097/MOL.0000000000000029)
Full text not currently available from Enlighten.
Publisher's URL: http://dx.doi.org/10.1097/MOL.0000000000000029
Abstract
The relationship between triglyceride levels and cardiovascular risk remains complex with large, high-quality epidemiological studies indicating that triglyceride levels do not predict risk beyond other lipids and usual classical risk factors, whereas studies of genetic polymorphisms suggest that triglycerides-related pathways may indeed have a causal factor. Statin therapy remains first-line therapy for cardiovascular risk reduction regardless of triglyceride levels.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Preiss, Dr David and Sattar, Professor Naveed |
Authors: | Preiss, D., and Sattar, N. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
Journal Name: | Current Opinion in Lipidology |
Publisher: | Lippincott Williams & Wilkins |
ISSN: | 0957-9672 |
ISSN (Online): | 1473-6535 |
University Staff: Request a correction | Enlighten Editors: Update this record